NCT02816346View on ClinicalTrials.gov

Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 12, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Healthy
Interventions
BIOLOGICAL

Shigella sonnei 53G

"Investigational Product: Shigella sonnei strain 53G (Lot 1794) Mode of Administration: Delivered with sodium bicarbonate orally after a 90 minute fast.~Dose: 500-1500 cfu (doses were to be increased or lowered based on results of preceding cohorts)"

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

PATH

OTHER

NCT02816346 - Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain | Biotech Hunter | Biotech Hunter